75 related articles for article (PubMed ID: 3580020)
1. [Effectiveness of various immunoglobulin preparations administered by the intravenous route in peritonitis in the rat model].
Hart H; Seifert J; Brendel W
Arzneimittelforschung; 1987 Feb; 37(2):170-4. PubMed ID: 3580020
[TBL] [Abstract][Full Text] [Related]
2. [Anaphylactic shock reaction following intravenous administration of 7S immunoglobulin in patients with hypogammaglobulinemia, especially in children with acute lymphoblastic leukemia (ALL)].
Manzke H; Seifert J
Klin Padiatr; 1987; 199(4):274-8. PubMed ID: 3116320
[TBL] [Abstract][Full Text] [Related]
3. Effects of intravenous gamma immunoglobulins treatment on severe peritonitis in rats.
Greenberg R; Haddad R; Kashtan H; Skornick Y; Kaplan O
Int J Surg Investig; 2001; 2(6):433-42. PubMed ID: 12678124
[TBL] [Abstract][Full Text] [Related]
4. [Intravenous immunoglobulins in newborn infants at risk of infection. Comparative efficacy of preparations 7S and 5S].
Bonanno Conti MI
Minerva Pediatr; 1990; 42(1-2):15-8. PubMed ID: 1692390
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro behaviour and in vivo efficacy of two 7S-immunoglobulin preparations for intravenous use.
Stephan W; Dichtelmüller H
Arzneimittelforschung; 1983; 33(11):1538-40. PubMed ID: 6686449
[TBL] [Abstract][Full Text] [Related]
6. Efficaciousness of immunoglobulin G prophylaxis on mortality and physiological variables in gram-negative peritonitis in rodents.
Emerson TE; Lurton JM; Collins MS
Circ Shock; 1985; 17(3):213-22. PubMed ID: 3907885
[TBL] [Abstract][Full Text] [Related]
7. Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
Cirioni O; Ghiselli R; Kamysz W; Orlando F; Silvestri C; Mocchegiani F; Di Matteo F; Kamysz E; Riva A; Rocchi M; Saba V; Scalise G; Giacometti A
Peptides; 2008 Jan; 29(1):31-8. PubMed ID: 18068869
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
[TBL] [Abstract][Full Text] [Related]
9. Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia.
Björkander J; Nikoskelainen J; Leibl H; Lanbeck P; Wallvik J; Lumio JT; Braconier JH; Pavlova BG; Birthistle K; Engl W; Walter S; Ehrlich HJ
Vox Sang; 2006 May; 90(4):286-93. PubMed ID: 16635071
[TBL] [Abstract][Full Text] [Related]
10. [Immunotherapy with immunoglobulins].
Briese V; Straube W
Zentralbl Gynakol; 1984; 106(24):1557-71. PubMed ID: 6085201
[TBL] [Abstract][Full Text] [Related]
11. Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned mice.
Fomsgaard A; Holder IA
APMIS; 1993 Mar; 101(3):229-34. PubMed ID: 8507460
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of gram-negative and gram-positive infections using 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection using intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
Infection; 1987; 15(1):60-8. PubMed ID: 3570485
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the properties of the component of plasmin-treated IgG and the relation between IgG aggregates and complement-fixing ability (author's transl)].
Funakoshi S
Hokkaido Igaku Zasshi; 1974 Nov; 49(6):522-35. PubMed ID: 4283370
[TBL] [Abstract][Full Text] [Related]
14. [The pathogenesis of immune complexes and the clinical intravenous use of IgG and enzyme-treated IgG preparation].
Sedlacek HH; Seiler FR
Beitr Infusionther Klin Ernahr; 1982; 9():80-94. PubMed ID: 6216882
[No Abstract] [Full Text] [Related]
15. The effects of desferrioxamin and vitamin E as supplements to antibiotics in the treatment of peritonitis in rats.
Soybir N; Soybir G; Lice H; Dolay K; Ozşeker A; Köksoy F
J R Coll Surg Edinb; 2002 Oct; 47(5):700-4. PubMed ID: 12463711
[TBL] [Abstract][Full Text] [Related]
16. The effect of one prophylactic dosage of antibiotics on experimentally induced lethal intraabdominal sepsis.
Brolin J; Lahnborg G; Nord CE
Acta Chir Scand; 1984; 150(3):239-44. PubMed ID: 6380178
[TBL] [Abstract][Full Text] [Related]
17. A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art process.
Teschner W; Butterweck HA; Auer W; Muchitsch EM; Weber A; Liu SL; Wah PS; Schwarz HP
Vox Sang; 2007 Jan; 92(1):42-55. PubMed ID: 17181590
[TBL] [Abstract][Full Text] [Related]
18. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections.
Nord CE; Lahnborg G
Eur J Surg Suppl; 1994; (573):45-9. PubMed ID: 7524795
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of immunoglobulins in gram-negative infections in experimentally induced peritonitis in the rat.
Frick S; Rudy T
Res Exp Med (Berl); 1985; 185(3):181-93. PubMed ID: 4023428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]